Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01041105 · ClinicalTrials.gov registry record
Gastric Bypass After Previous Anti-reflux Surgery
A clinical trial of Gastroesophageal Reflux Disease and Clinically Severe Obesity, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT01041105 is a study of Gastroesophageal Reflux Disease and Clinically Severe Obesity that has completed, run by University of California, San Francisco. The registered enrollment target is 22 participants, below the 347-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01041105, a study of Gastroesophageal Reflux Disease and Clinically Severe Obesity, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to describe the clinical presentation, indications, and operative treatment as well as assess the morbidity, mortality, and overall performance of revisional Roux-en-Y gastric bypass (RYGB) after either failed or functional antireflux surgery "ARS" in obese patients. With such information, we hope to determine which features might assist us in advancing our knowledge about Gastro-Esophageal Reflux Disease "GERD", the best option for primary ARS, and mechanisms of failure in the obese population as well as in identifying predictors of outcome after revisional surgery in this population.
Conditions Studied
Study Locations (1)
California
- UCSF Fresno Center for Medical Education and Research - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01041105
The ClinicalTrials.gov registry entry for NCT01041105 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 347-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastroesophageal Reflux Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01041105 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01041105 about?
NCT01041105 is a clinical study titled "Gastric Bypass After Previous Anti-reflux Surgery". The goal of this study is to describe the clinical presentation, indications, and operative treatment as well as assess the morbidity, mortality, and overall performance of revisional Roux-en-Y gastric bypass (RYGB) after either failed or functional antireflux surgery "ARS" in obese patients. With s...
What is the current status of trial NCT01041105?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2008-12. Estimated completion is 2009-12.
What conditions does trial NCT01041105 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux Disease, Clinically Severe Obesity.
Who is sponsoring clinical trial NCT01041105?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01041105 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
ACTIVE NOT RECRUITING
-
GCC Agonist Signal in the Small Intestine
ACTIVE NOT RECRUITING · Phase 1
-
Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Gastroesophageal Reflux Disease
All registered trials for this condition
Clinically Severe Obesity
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.